Recent Advances in the Treatment of Alopecia Areata

In this MEDcast episode, Raj Chovatiya, MD, PhD, and George Han, MD, PhD, interview Brett King, MD, PhD, to discuss the latest advances in the treatment of alopecia areata.

EP: 1.Impact of Alopecia Areata on Quality of Life, and Current Standard of Treatment

EP: 2.JAK Inhibitor Baricitinib for Treatment of Alopecia Areata

EP: 3.Analyzing Phase 3 Clinical Trial Data of Baricitinib in Alopecia Areata

EP: 4.Novel Mechanisms of Action for Treatment of Alopecia Areata

EP: 5.Physician and Patient Communication for the Management of Alopecia Areata

Now Viewing

EP: 6.Recent Advances in the Treatment of Alopecia Areata

EP: 7.The Pathophysiology of Alopecia Areata

EP: 8.The Benefits of Early Diagnosis of Alopecia Areata

EP: 9.Patient Factors and Other Considerations for Treatment Selection

EP: 10.Treatment Options for Alopecia Areata

EP: 11.Review of FDA Approved JAK Inhibitors for Alopecia Areata

EP: 12.JAK Inhibition in the Treatment of Alopecia Areata

EP: 13.Assessing Risk and Safety of JAK Inhibitors

EP: 14.Real-World Clinical Experience With JAK Inhibitors

EP: 15.Challenges With the Use of JAK Inhibitors

EP: 16.Considerations Regarding Patient Selection for JAK Inhibitors

EP: 17.The Role of Health Care Providers in Raising Awareness About Alopecia Areata

EP: 18.Future Directions in the Treatment of Alopecia Areata

Related Videos